Floatz logo

Irinotecan

Liver Metastases

Kamya SankarSmall moleculePhase 3Active
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
67/ 100
Competitive Position
73/ 100

Competitive context

35 Active assets in the Liver Metastases cohort.

Asset / SponsorPhaseRating
Eloxatin
Sun Yat-sen University
Phase 3BB
FLUOROURACILUM
Sun Yat-sen University
Phase 3BB
Calcium folinate pentahydrate
Fudan University
Phase 3BB
Ipilimumab
Vastra Gotaland Region
Phase 3B
Nivolumab
University of Wisconsin, Madison
Phase 3B

View all 50 →

Same molecule, other indications

Irinotecan is also rated in:

rectal cancerDormant
BBB
Indicative ·
78 / 100
View asset →
exocrine pancreatic carcinomaDormant
BBB
Indicative ·
78 / 100
View asset →
Peritoneal NeoplasmsDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →